Navigation Links
Anadys Pharmaceuticals Reports Third Quarter 2010 Financial Results and Highlights
Date:11/8/2010

ommon stock.  $25.0 million in gross proceeds were raised, before deducting underwriting discounts and commissions and other offering expenses.  Proceeds from the offering are to support the Phase IIb study of ANA598, as well as for general corporate purposes, including working capital.  Concurrent with the announcement of the offering, Anadys announced its plans to resume clinical investigation of ANA773. Anadys continues to work with Lazard Frères & Co. llc. to explore potential strategic transactions, in parallel with moving the ANA598 and ANA773 programs forward.


  • Receipt of Federal Grant.  In late October, Anadys received notification of a grant of approximately $0.5 million from the U.S. Government for the ANA598 and ANA773 programs under the Qualifying Therapeutic Discovery Project program.  The proceeds from the grant are planned to be used for clinical trial related expenses for the ANA598 and ANA773 programs.Conference Call Webcast Anadys will host a conference call and webcast at 5:00 pm Eastern Standard Time today to discuss its third quarter 2010 financial results and highlights.  A live webcast of the call will be available online at www.anadyspharma.com.  A telephone replay will also be available approximately one hour after completion of the call.  To access the telephone replay, dial 888-286-8010 (domestic) or 617-801-6888 (international), passcode 26363504.  The webcast and telephone replay will be available through November 22, 2010.

    About Anadys Anadys Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of hepatitis C. The Company believes hepatitis C represents a large unmet medical need in which meaningful improvements in treatment outcomes may be attainable with the introduction of new medicines. Anadys is p
    '/>"/>


  • SOURCE Anadys Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
    2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
    3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
    4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
    5. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
    6. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
    7. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
    8. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
    9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
    10. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
    11. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2015)... 2015  Boston Children,s Hospital physicians report the ... of their anatomy before undergoing high-risk brain procedures. ... in the brain,s blood vessels) that posed special ... the Journal of Neurosurgery: Pediatrics , the ... synthetic resins to create custom, high-fidelity models of ...
    (Date:7/31/2015)... July 31, 2015 Egalet Corporation (Nasdaq: ... pharmaceutical company focused on developing, manufacturing and marketing ... its previously announced underwritten public offering of 7,666,667 ... offering price of $11.25 per share. The shares ... shares issued upon the exercise in full by ...
    (Date:7/31/2015)... According to a new market research report ... Dual-Energy X-ray Absorptiometry (DEXA), Skinfold Calipers, Air Displacement Plethysmography ... to 2019", published by MarketsandMarkets, the global Body Composition ... is estimated to grow to $1,425.7 Million by 2019, ... 2019. Browse 41 market data Tables ...
    Breaking Medicine Technology:3D Printing Helps Doctors Rehearse Complex Brain Procedures 23D Printing Helps Doctors Rehearse Complex Brain Procedures 33D Printing Helps Doctors Rehearse Complex Brain Procedures 4Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4
    ... Technologies, a global leader in scientific asset management, biomaterial ... in the AMDeC Vendor Partnership Program. This program provides ... products and services crucial to medical research and will ... BioStorage Technologies. AMDeC is a consortium ...
    ... 17, 2011 Ingenious Med, the leading platform for ... is now available on the App Store for iPhone, ... as part of the company,s presence at the Hospital ... enables Ingenious Med,s 9,000 users to access the charge ...
    Cached Medicine Technology:BioStorage Technologies Partners with AMDeC, LLC to Provide Tissue Storage and Cold Chain Logistics Services to Academic Medical Research Institutions 2BioStorage Technologies Partners with AMDeC, LLC to Provide Tissue Storage and Cold Chain Logistics Services to Academic Medical Research Institutions 3HIMSS11: Ingenious Med Launches Billing and Data Capture App for iPhone, iPod touch and iPad 2
    (Date:8/1/2015)... ... August 01, 2015 , ... Lume Wellness creators Alex, Robert, and Sam have ... the Apple AppStore. , The app is designed to track various metrics of ... tool to view personal health and use this information for positive behavior modification. Lume ...
    (Date:8/1/2015)... ... August 01, 2015 , ... On March 19, 2015 Phil Valentine – the Executive Director of ... Appalachian Trail by stepping off Springer Mountain and heading north. Since that day, Phil ... reached Connecticut and was greeted by friends and family. He visited CCAR and left ...
    (Date:7/31/2015)... ... July 31, 2015 , ... When the weather turned ... debuted their new type of sod called Leisure Time(TM) zoysia . It's nicknamed ... , To commemorate introduction of this new type of sod, Super-Sod is giving away ...
    (Date:7/31/2015)... ... ... Ticket Down is a reliable source for authentic tickets for the 2015 ... festival will end on Sunday, August 2nd. , Music fans have traveled ... unique and unbelievably popular festival attracts the best in entertainment from around the world. ...
    (Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... its new store run by GoodThreads. The store can be accessed by visiting ... designs, many of which are customizable. The best part: whenever a product is ...
    Breaking Medicine News(10 mins):Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Mesothelioma Organization Launches New Store 2Health News:Mesothelioma Organization Launches New Store 3
    ... Toxins can be removed and pollutants can be trapped through ... study. The local water quality can also be improved as ... has been around for 10 to 15 years, but there ... US researchers at the University of Connecticut planted two rain ...
    ... Hong Kong’s Life of Life Healing Spa is increasingly getting ... fat after the very first session. // Owner Karen Chu ... a good degree of success since the spa first began ... fire treatment given here has not yet resulted in any ...
    ... chances of quitting smoking as the presence of nicotine from ... from inhaled source leading to loss of interest in smoking ... researchers have reported their finding in the Journal Nicotine and ... occurring due to use of nicotine patches. ,Professor ...
    ... William Honer and researchers have reported the results of ... which they found in a trial conducted in 68 ... drugs Clozapine and Risperdal for treatment of Schizophrenia. ... not work positively in controlling the symptoms of Schizophrenia ...
    ... system has been claimed by British Columbia, in spite of ... services // are concerned. The worst health system in the ... last in terms of patient satisfaction and performance. The Conference ... ,Money does not appear to play a prominent where good ...
    ... that he has a plan that will enable the uninsured ... // The taxpayers, employers and the recipients of the insurance ... the potential to benefit tens of thousands of city residents. ... care legislation said that he supports the mayor's idea and ...
    Cached Medicine News:Health News:San Francisco Mayor Proposes An Alternate Plan For The Uninsured City Residents 2
    The Small External Fixator has straight or angled frames, independent pin placement, and combines easily with Large and Medium External Fixator frames....
    The Medium External Fixator has a medium Combination Clamp that connects rod to rod or pin to rod as well as a Medium Multi-Pin Clamp that connects pins to rods allowing parallel pin placement....
    ... Holding Clamps have a slender design contributes ... tensioning of Kirschner wires. The Connecting Clamp ... Rods and/or Connecting Bar. Uses 3.0 mm ... Kirschner wires eliminate need to predrill and ...
    ... the DJD® II are to allow active or ... the articular surfaces of the elbow and collateral ... is designed to replicate the elbow's axis of ... articular surfaces from damaging each other. The DJD® ...
    Medicine Products: